INTRODUCTION
Orofacial granulomatosis (OFG) is a nonspecific term encompassing a group of immunologically mediated, persistent or recurrent, inflammatory, granulomatous entities that manifest as soft tissue enlargement of the lips and face, with a spectrum of other orofacial features. 1 It has been proposed that OFG with localized granulomatous inflammation of the lips (known as Miescher cheilitis), Crohn's disease (CD) and Melkersson-Rosenthal syndrome (MRS) (lip edema, fissured tongue and facial paralysis triad) are all part of the same disease spectrum. [1] [2] [3] There is no clear consensus on the definition of OFG, however, the main concern is to rule out CD. 4 Treatment is often unsatisfactory. 5 Numerous treatment strategies have been proposed, with no clear consensus on the matter. Pharmacological agents include topical (corticosteroids and calcineurin inhibitors), intralesional (corticosteroids), and systemic alternatives (corticosteroids, azathioprine, thalidomide, metronidazole and minocycline). 1, 6 At least three authors propose a cinnamonand benzoate-free diet as first-line therapy. [7] [8] [9] We present a review of the role of diet in the treatment of OFG, with two illustrating clinical cases treated with this same modality.
REPORT OF THE CASES

Patient 1
A 22-year-old Hispanic man presented to our oral medicine clinic with a one-year history of oral ulcers and a painless, intermittent, diffuse lower lip swelling. Over time, soft tissue enlargement became persistent.
He had a personal history of bronchial hyperresponsiveness and hay fever under treatment with oral fexofenadine. He denied any history of skin lesions, known allergies, food complaints or any symptoms of inflammatory bowel disease, present or past. With the diagnosis of orofacial granulomatosis, the patient was referred to a gastroenterologist to rule out Crohn's disease and to an immunologist for the study of allergies. 
DISCUSSION
OFG is considered a rare entity, with unknown prevalence and no specific ethnic or gender predilection. 5 Within the United Kingdom, the majority appears to be concentrated in Scotland. 10 Though it may present at any age, it is more frequently diagnosed in children and young adults (median age of diagnosis: 28 years).
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The exact etiology of idiopathic OFG remains unknown.
Current knowledge suggests a multifactorial relation between the immune system, environmental exposure and genetic susceptibility. 10 Up to 80% have an IgE-mediated clinical allergy (e.g., hay fe- The prevalence of facial palsy is unclear (8% -57%). 5 Other neurologic symptoms may exist.
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Histopathology should always reveal a chronic inflammatory infiltrate. 17 Although it is considered a granulomatous entity, less Some authors consider restrictive diets as first-line treatment, with good response and better acceptability to a cinnamon-and benzoate-free diet over pharmacological agents. 7, 8, 9 This is based in the fact that cinnamon and benzoate compounds are referred to as the most common triggers. 5 Chocolate also merits avoidance. Properly supervised, it is nutritionally adequate and, according to a review by Campbell et al., it was deemed beneficial in 54% -78% of patients, with 23% requiring no adjunctive therapies. Follow-up is important, since treatment is usually programed in a long-term basis. Prognosis is good, but patients must be informed that recurrence is common and often unexplained. 7 Clinical outcome is unpredictable, however, persistent orofacial swelling can be prevented when OFG is diagnosed and treated early on. 17, 19 Neurologic signs usually appear at an initial stage and are unlikely to develop afterwards. 1 Long-term follow-up is particularly important in patients under 16-years-old, since they seem to have a higher risk of developing CD later in life (up to 40%). 2, 4, 22 OFG represents a diagnostic challenge, considering clinical onset can be highly polymorphous, and, due to its rarity, it is not very well known in the medical community. 16 There is still no consensus on the definition of OFG, and even though certain treatment alternatives have proven beneficial, more information is needed before a definite recommendation can be formulated.
One of the main difficulties in establishing a therapeutic course of action relates to the fact that this disease has a very low prevalence, and gathering enough cases to perform a study with statistically significant results remains a challenge. Future investigations in dietary therapy should consider a multicenter approach, adding control groups and performing double blind randomized controlled trials.
In both our cases we were able to see a good initial response to restriction of the allergens that they tested positive for; however, 
